BioNTech CEO Predicts New Vaccine Formulas May Be Necessary in 2022

A new study awaiting peer review has found that those administered the full two doses of the Pfizer-BioNTech COVID-19 vaccine possess high levels of neutralising antibodies to combat the original strain of the contagious disease. However, these levels drop considerably - nearly ten-fold - within seven months after the second dose.